Buprenorphine Vet Transdermal Patch from Japan
Transdermal patches delivering buprenorphine, a semi-synthetic opioid alkaloid, provide sustained pain relief for cats and dogs. Designed for veterinary use in measured doses via transdermal administration. Classified in HTS 3004.49.00.05 for alkaloid-containing veterinary therapeutics.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Document transdermal system specs and release rate for alkaloid delivery; FDA vet approval mandatory
• Label clearly 'veterinary use' to prevent human med confusion